Growth Healthtech Independent growth-focused Healthtech investor with international reach (Paris and San Francisco) actively backing commercial-stage medical devices, digital health, life sciences tools, and healthcare data companies—potential partners or customers in portfolio companies seeking strategic funding or collaboration.

Recent Financing Momentum Significant fundraising activity including a €400M financing round in 2025 signals strong scale-up capabilities and appetite for large healthtech deals, presenting opportunities for co-investment discussions, strategic partnerships, or advisory services with potential portfolio synergies.

Acquisitions & Tools Recent acquisitions of Matrix Requirements and Galen Data indicate a focus on ALM/eQMS software, cloud connectivity, and regulatory/compliance tooling for medical devices—sales opportunities for software, data integration, and compliance solutions to support portfolio companies.

Key Leadership Additions Appointment of senior advisor and expansion of leadership, including Dr. Oern Stuge, suggests a strengthened network for strategic partnerships, market access, and business development leads that could facilitate introductions or co-selling opportunities with European Healthtech firms.

Geographic Footprint Operations across Paris and San Francisco with a European focus and U.S. portfolio activity present; opportunities exist for cross-border pilots, regulatory navigation support, and multi-market deployments of healthtech solutions to accelerate growth for portfolio companies.